| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/06/2011 | EP1467749B1 Thrombin derived peptides for promoting cardiac tissue repair |
| 04/06/2011 | CN1730476B Aromatic amine ketone compounds, its synthesis method, pharmaceutical composition containing same and uses |
| 04/06/2011 | CN102006868A Iron and zinc based pharmaceutical formulation for iron deficiency treatment |
| 04/06/2011 | CN102002483A Hematopoietic targeted helper adenovirus and application thereof |
| 04/06/2011 | CN102002110A Preparation method of polysaccharides from sea cucumber |
| 04/06/2011 | CN102002081A 9-O-beta-D-glucosyl nandinine as well as preparation method and application thereof |
| 04/06/2011 | CN102002053A Tetrahydro thienopyridine derivative for treating |
| 04/06/2011 | CN102002052A Ginkgolides K and compound thereof as well as preparation method and use thereof |
| 04/06/2011 | CN102001963A Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate |
| 04/06/2011 | CN102001962A Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate |
| 04/06/2011 | CN102000247A Oral traditional Chinese medicine decoction for treating uterine bleeding |
| 04/06/2011 | CN102000157A Medicinal liquor with treatment and health-care functions |
| 04/06/2011 | CN102000140A Novel method for synchronously quantifying matrine and oxymatrine in kuh-seng and preparations of kuh-seng |
| 04/06/2011 | CN102000126A Ginkgo flavone tablet and preparation method thereof |
| 04/06/2011 | CN102000125A Ginkgo flavone extraction method |
| 04/06/2011 | CN102000124A Ginkgo biloba extract oral liquid and preparation method thereof |
| 04/06/2011 | CN102000123A Ginkgo flavone capsule and preparation method thereof |
| 04/06/2011 | CN102000113A Method for preparing nano donkey-hide gelatin granules with polymer as carrier |
| 04/06/2011 | CN102000111A Preparation method of emergency survival hemostatic based on natural zeolite in Jinyun of Zhejiang |
| 04/06/2011 | CN102000086A Application of asiatic acid in preparing medicament for treating or preventing pancreatic fibrosis |
| 04/06/2011 | CN102000079A Application of nicotinamide mononucleotide ribose phosphate transferase inhibitor |
| 04/06/2011 | CN102000031A Method for preparing fluorocarbon microspheres |
| 04/06/2011 | CN102000025A Novel painless diluent, dilution compatibility method and application of alprostadil fat emulsion preparation |
| 04/06/2011 | CN102000022A Recombined bifunctional plasmin freeze-drying preparation for injection and preparation method thereof |
| 04/06/2011 | CN102000021A Stable chlorine dioxide sustained-release gel preparation and preparation method and application thereof |
| 04/06/2011 | CN101780251B Chinese traditional medicine composition for eliminating blood toxicity and improving blood viscosity and preparation method thereof |
| 04/06/2011 | CN101757347B Clinopodium polycephalum band-aid and preparation method thereof |
| 04/06/2011 | CN101697988B Taste hiding composition and application thereof in Xuesaitong chewable tablet |
| 04/06/2011 | CN101670069B Medicament for treating leukopenia |
| 04/06/2011 | CN101653570B Traditional Chinese medicine for increasing human leukocytes and platelets |
| 04/06/2011 | CN101627988B Application of structure modified products of salvianolic acid B in pharmacy |
| 04/06/2011 | CN101625313B Method for measuring content of tannide in nakedflower beautyberry |
| 04/06/2011 | CN101618056B Great burdock achene Chinese herb soft capsule preparation and preparation method thereof |
| 04/06/2011 | CN101536854B Health-caring process quilt |
| 04/06/2011 | CN101475936B EDRF gene fragment |
| 04/06/2011 | CN101412995B Polyethyleneglycol modified aprotinin and preparation thereof |
| 04/06/2011 | CN101406491B Oil-in-water Cordyceps sinensis emulsion and preparation technique |
| 04/06/2011 | CN101361858B Medicine for treating aplastic anemia |
| 04/06/2011 | CN101337020B Traditional Chinese medicine composition for preventing frog gastroenteritis and hemorrhagic disease |
| 04/06/2011 | CN101322778B Double-layer sustained release tablets for compensating iron and preparation thereof |
| 04/06/2011 | CN101317676B Puffed food made of sacred lotus husk |
| 04/06/2011 | CN101270151B Peptide medicaments for accelerating medulla hematopoiesis cell proliferation |
| 04/06/2011 | CN101234181B Medicament for preventing and treating leukopenia used in tumor radiotherapy and chemotherapy course |
| 04/06/2011 | CN101095720B Method for preparing total salvianolic acid and the application in the preventing and treating of diabetes and the complication thereof |
| 04/06/2011 | CN101031548B Salts of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy) phenylmethyl) carbamide and their preparation |
| 04/05/2011 | US7919614 Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919462 Inhibitors of human plasmin derived from the Kunitz domains |
| 04/05/2011 | US7919455 Marked peptides having affinity for a phospholipid and uses |
| 04/05/2011 | US7919329 Method for screening for agents that affect food intake |
| 04/05/2011 | CA2574822C Quinazoline derivatives and their use in the treatment of thrombocythemia |
| 04/05/2011 | CA2514681C Methods and compositions for inhibition of angiogenesis |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 03/31/2011 | WO2011038157A2 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins |
| 03/31/2011 | WO2011037760A2 Composite layered hemostasis device |
| 03/31/2011 | WO2011037281A1 Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036533A1 Pharmaceutical composition comprising prasugrel and triflusal |
| 03/31/2011 | WO2011036467A1 Products useful in the treatment of haemophilia |
| 03/31/2011 | WO2010131910A3 Composition for improving blood circulation containing fermented tea, and pharmaceutical and health-food compositions comprising the same |
| 03/31/2011 | WO2010129890A3 Compounds and methods for inhibiting platelet aggregation |
| 03/31/2011 | WO2010121122A3 Biomechanical induction of hematopoiesis |
| 03/31/2011 | WO2010108028A3 Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same |
| 03/31/2011 | WO2010108016A3 Compositions and methods for sparing muscle in renal insufficiency and during hemodialysis |
| 03/31/2011 | US20110077306 Stat3 inhibiting compositions and methods |
| 03/31/2011 | US20110077290 Heterocyclic compounds and thrombopoietin receptor activators |
| 03/31/2011 | US20110077267 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent |
| 03/31/2011 | US20110077266 Diamine Derivatives |
| 03/31/2011 | US20110077255 Substituted xanthine derivatives |
| 03/31/2011 | US20110077236 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 03/31/2011 | US20110077232 Compositions comprising atorvastatin 4-(nitrooxy) butyl ester and a hypolipidemic drug |
| 03/31/2011 | US20110077214 Method for treating hyponatremia employing an sglt2 inhibitor and composition containing same |
| 03/31/2011 | US20110077212 Therapeutic uses of sglt2 inhibitors |
| 03/31/2011 | US20110077203 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use |
| 03/31/2011 | US20110077202 Targeted Coagulation Factors and Method of Using the Same |
| 03/31/2011 | US20110077194 Method for Treating or Preventing a Functional Vitamin B12 Deficiency in an Individual and to Medical Compositions for Use in Said Method |
| 03/31/2011 | US20110076326 Modified protein excipient for delayed-release tablet |
| 03/31/2011 | US20110076319 Bioresorbable metal stent with controlled resorption |
| 03/31/2011 | US20110076314 Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom |
| 03/31/2011 | US20110076293 Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 03/31/2011 | US20110076292 Benzoxazepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076291 Benzoxepin pi3k inhibitor compounds and methods of use |
| 03/31/2011 | US20110076250 Biodegradable Absorbents and Methods of Preparation |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/30/2011 | EP2302045A1 Enzymatic conversion of blood group B, and AB red blood cells using an alpha-galactosidase with unique substrate specificities and kinetic properties |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301930A1 Thrombin receptor antagonists |
| 03/30/2011 | EP2301922A1 Pyridone compound |
| 03/30/2011 | EP2300462A1 Macrocyclic urea and sulfamide derivatives as inhibitors of tafia |
| 03/30/2011 | EP2300435A2 Heterocyclic compounds as factor ixa inhibitors |
| 03/30/2011 | EP1517710B1 Pegylated factor vii glycoforms |
| 03/30/2011 | EP1503773B1 Hepatoprotective activity of 2 -p-hydroxybenzoylmussaenosidic acid |
| 03/30/2011 | EP1305007B1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/30/2011 | CN1849133B Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
| 03/30/2011 | CN1489583B Novel physiologically active substance |
| 03/30/2011 | CN101998989A Identification of TRPML3 (MCOLN3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release |
| 03/30/2011 | CN101998958A Thieno-and furo-pyrimidine modulators of the histamine h4 receptor |
| 03/30/2011 | CN101998953A 2-phenyl-4-cyclopropyl-pyrimidine derivatives |